US Stock MarketDetailed Quotes

APLS Apellis Pharmaceuticals

Watchlist
  • 49.860
  • +1.930+4.03%
Close Apr 26 16:00 ET
  • 49.860
  • 0.0000.00%
Post 16:01 ET
6.05BMarket Cap-11204P/E (TTM)

Apellis Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Business Currency:USD
2023/FY
Stock NameRevenueRatio
Product revenue, net366.28M92.36%
Licensing and other revenue30.31M7.64%
Region Currency:USD
2023/FY
Stock NameRevenueRatio
United States396.59M100.00%

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg
Concept Gene Editing
Gene Editing
Intraday+0.41%